LAIYANG, China, Nov. 3 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced the launch of its new corporate website with the domain address http://www.genesispharmaceuticals.com .
The website features an overview of the Company, its corporate history, current products and recent news. The website includes an investor relations section from which users can download presentations and filings.
"We are very pleased to officially launch our new corporate website. We believe that this new website will provide a quick and easy way for our customers, investors and business partners to access key information about Genesis Pharmaceuticals and communicate directly with us," said Mr. Wubo Cao, Chief Executive Officer of Genesis. " Through frequent and regular updates, we believe our website will be an effective tool that will increase awareness of our Company's products among consumers, enhance contacts with our investors, and raise awareness of our business within the investment community."
About Genesis Pharmaceuticals Enterprises, Inc.
Genesis Pharmaceuticals Enterprises, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Northeast China in an Economic Development Zone in Laiyang City, Shandong province. Genesis is a major pharmaceutical company in China producing tablets, capsules, and granules for both western and Chinese herbal- based medical drugs.
Safe Harbor Statement
Certain statements in this press release that are not historical facts
are "forward-looking statements" within the meaning of the Private
Securities Litigation Reform
|SOURCE Genesis Pharmaceuticals Enterprises, Inc.|
Copyright©2008 PR Newswire.
All rights reserved